Clinical Research Trials Available

Search Results

8374-CL-0101

Disease Types: Solid Tumors

TAS-10058010

Disease Types: Solid Tumors

16-214-02

Disease Types: Solid Tumors

ASG-22CE-132

Disease Types: Solid Tumors

M16-074

Disease Types: Solid Tumors

G1T28-05

Disease Types: Lung cancer

M14-237

Disease Types: Solid Tumors

17-058

Disease Types: Brain

16-233

Disease Types: Gynecological

16-228

Disease Types: Breast

16-128

Disease Types: Breast

15-179

Disease Types: Multiple Myeloma

16-208

Disease Types: TNBC Triple-Negative Breast Cancer

16-097

Disease Types: TNBC Triple-Negative Breast Cancer

16-127

Disease Types: Metastatic Castration Resistant Prostate Cancer

16-159

Disease Types: Metastatic Castration Resistant Prostate Cancer

16-156

Disease Types: Non-Small Cell Lung Cancer, NSCLC

16-006

Disease Types: Non-Small Cell Lung Cancer, NSCLC

16-140

Disease Types:

GO-001

Disease Types: Lung cancer

CP-MGD009-01

Disease Types: Solid Tumors

CTMX-M-072-001

Disease Types: Advance Solid Tumor, Solid Tumor Lymphoma., Solid Tumors

AbbVie M15-891

Disease Types: Advance Solid Tumor

AbbVie M15-862

Disease Types: Solid Tumors

161-59

Disease Types: Prostate

MRTX-500

Disease Types: NSCLC

RRX-001-211-01

Disease Types: Neuroedocrine, NSCLC, Ovarian, SCLC

16-139

Disease Types: Solid Tumors

16-135

Disease Types: Lung cancer, NSCLC

16-130

Disease Types: Colorectal

16-016

Disease Types: Solid Tumors

14-048

Disease Types: Solid Tumors

15-146

Disease Types: Breast, TNBC Triple-Negative Breast Cancer

15-231

Disease Types: Lung cancer

16-041

Disease Types: Metastic Malignancies

Astellas 2215-CL-0302

Disease Types: Acute Myeloid Leukemia

Mirati 516-001

Disease Types: Solid Tumors

AbbVie M15-394

Disease Types: Solid Tumors

15-146

Disease Types: TNBC Triple-Negative Breast Cancer

15-215

Disease Types: Solid Tumors

14-171

Disease Types: Solid Tumors

4132-CL-0001

Disease Types: Solid Tumor Lymphoma.

4132-CL-0001

Disease Types:

INCB24360-202

Disease Types: Solid Tumor Lung

15-239

Disease Types: Solid Tumors

HALO-107-101

Disease Types: NSCL/Gast

MM-121-01-02-09

Disease Types: Lung cancer, NSCLC

CINC280A2201

Disease Types: Lung cancer, NSCLC

AP32788-15-101

Disease Types: Lung cancer, NSCLC

ACE-ST-203

Disease Types: Lung cancer, NSCLC

15-183

Disease Types: Lung cancer, NSCLC

14-158

Disease Types: NSCLC

CPDR001X2201

Disease Types: Nasopharyngeal

MMRF-002

Disease Types: Multiple Myeloma

15-137

Disease Types: Multiple Myeloma

15-247

Disease Types: Met CRPC Men with Metastatic Castration Resistant Prostate Cancer

CINC280B2201

Disease Types: EGFR mutated, cMET amplified, locally advanced/metastatic non-small cell lung cancer, Lung cancer, Met NSCLC

15-226

Disease Types:

14-192

Disease Types: Breast, Breast Cancer and Bone Metastases

ADCT-301-001

Disease Types: Hodgkin Lymphoma, Non-Hodgkin's Lymphoma

STARTRK-2

Disease Types: Solid Tumors

ADCT-301-001

Disease Types: Hodgkin Lymphoma, Non-Hodgkin's Lymphoma

ADCT-301-002

Disease Types: Acute Myeloid Leukemia

PCYC-1128-CA

Disease Types: Gastric/Gastroesophageal Junction

13-053

Disease Types: Gastric/Gastroesophageal Junction

ML25749

Disease Types: Breast

USOR 14-192
A PHASE I, MULTICENTER, OPEN-LABEL, TWO-PART, DOSE-ESCALATION STUDY OF RAD1901 IN POSTMENOPAUSAL WOMEN WITH ADVANCED ESTROGEN RECEPTOR POSITIVE AND HER2-NEGATIVE BREAST CANCER

Disease Types: Breast

ProNAi Theapeutics PNT2258-03-DLBCL “WOLVERINE”
A PHASE II STUDY OF PNT2258 IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA

Disease Types: Diffuse Large B-cell Lymphoma

DanaFarber-MMRC DF14-453 “EloRVD”
An Open-Label, Single Arm, Phase 2a Study of Bortezomib, Lenalidomide, Dexamethasone and Elotuzumab in Newly Diagnosed Multiple Myeloma

Disease Types: Multiple Myeloma

Clovis CO-1686-033
A Phase 1/2 study of the safety and efficacy of rociletinib when administered in combination with trametinib in patients with activating EGFR mutation-positive advanced or metastatic non-small cell lung cancer (NSCLC)

Disease Types: Non-Small Cell Lung Cancer

ADC Therapeutics ADCT-301-001
A Phase 1 Adaptive Dose-Escalation Study to Evaluate the Tolerability, Safety, Pharmacokinetics, and Antitumor Activity of ADCT-301 in Patients with Relapsed or Refractory Hodgkin Lymphoma and Non-Hodgkin Lymphoma

Disease Types: Hodgkin Lymphoma, Non-Hodgkin's Lymphoma

USOR 13-177
A Phase II, Open-Label Study of Obinutuzumab Plus Bendamustine (BG) in Patients with Previously Untreated Chronic Lymphocytic Leukemia

Disease Types: Chronic Lymphocytic Leukemia

Benovus Bio, Inc. BB-MPI-03-HEM-01
Phase I Study of an Oncofetal Antigen (“OFA”) Multi-Peptide Immunotherapy (“BB-MPI-03”) in Subjects with Hematologic Cancer

Disease Types: Acute Myeloid Leukemia, Multiple Myeloma, Myelodysplastic Syndrome

USOR 14-171
A Phase Ib Clinical Study of BBI608 and BBI503 Administered in Combination to Adult Patients with Advanced Solid Tumors

Disease Types: Solid Tumors

USOR 14-052
A Phase 2, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of Eribulin Mesylate Administered Biweekly (Q2W) for Subjects with Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Metastatic Breast Cancer

Disease Types: Breast

MedImmune CD-ON-MEDI4736-1108
A Phase 1/2 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI4736 in Subjects With Advanced Solid Tumors

Disease Types: Solid Tumors

AstraZeneca D5160C00019
A Phase I, Open-Label, Non-Randomised, Multicentre Study to Assess the Effect of AZD9291 on the Pharmacokinetics of Rosuvastatin (a Sensitive BCRP Substrate) in Patients with EGFRm Positive NSCLC whose disease has Progressed on an EGFR TKI

Disease Types: Non-Small Cell Lung Cancer

AstraZeneca 4193C00003 “CONDOR”
A Phase II, Randomized, Open-Label, Multi-Center, Global Study of MEDI4736 Monotherapy, Tremelimumab Monotherapy, and MEDI4736 in Combination with Tremelimumab in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)

Disease Types: Head and Neck, Squamous

Astellas 4132-CL-0001
An Open-Label, Dose-Escalation/Expansion Phase 1 Study of ASP4132 Given Orally to Subjects with Advanced Refractory Solid Tumors and Lymphoma

Disease Types: Hodgkin Lymphoma, Mantle Cell Lymphoma, Non-Hodgkin's Lymphoma, Solid Tumors

USO 14-125
Modular phase II study to link targeted therapy to patients with pathway activated tumors: Module 6 – BGJ398 for patients with tumors with FGFR genetic alterations

Disease Types: Solid Tumors

USOR 14-114 “TIGER 1”
A Randomized, Open-Label, Phase II Study of CO-1686 or Erlotinib as First-Line Treatment of Patients with EGFR-Mutant Advanced Non-Small Cell Lung Cancer (NSCLC)

Disease Types: Non-Small Cell Lung Cancer

AstraZeneca D4193C00001 “HAWK”
A Phase II, Multi-Center, Single-Arm, Global Study of MEDI4736 Monotherapy in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)

Disease Types: Head and Neck

Clovis CO-1686-019 “TIGER 2”
A Phase 2, Open-Label, Multicenter, Safety and Efficacy Study of Oral CO-1686 in Patients with Previously Treated Mutant EGFR Non-Small Cell Lung Cancer (NSCLC) Harboring the T790M Resistance Mutation

Disease Types: Non-Small Cell Lung Cancer

Astellas 2215-CL-0101
A Phase 1/2 Open-Label, Dose Escalation Study Investigating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ASP2215 in Patients with Relapsed or Refractory Acute Myeloid Leukemia

Disease Types: Acute Myeloid Leukemia

Incyte INCB 18424-266
A Randomized, Double-Blind Phase 2 Study of Ruxolitinib or Placebo in Combination With Pemetrexed/Cisplatin and Pemetrexed Maintenance for Initial Treatment of Subjects With Nonsquamous Non–Small Cell Lung Cancer That Is Stage IIIB With Pleural/Pericardial Effusion, Stage IV, or Recurrent

Disease Types: Non-Small Cell Lung Cancer

11-282
A phase 2 open-label study of brentuximab vedotin in front-line therapy of Hodgkin lymphoma (HL) in adults age 60 and above

Disease Types: Hodgkin Lymphoma

USO 13-204
Phase 1 Study of Mifepristone in Combination with Eribulin in Patients with Locally Advanced/Metastatic Breast Cancer with a Dose Expansion Cohort in Patients with Triple Negative Breast Cancer

Disease Types: Breast

USO 13-060
A Phase 1 Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-42756493, a pan-Fibroblast Growth Factor Receptor (FGFR) Tyrosine Kinase Inhibitor, in Subjects With Advanced or Refractory Solid Tumors or Lymphoma

Disease Types: Diffuse Large B-cell Lymphoma, Mantle Cell Lymphoma, Non-Hodgkin's Lymphoma, Solid Tumors

USOR 13-053
A Phase Ib/II Clinical Study of BBI608 Administered with Paclitaxel in Adult Patients with Advanced Malignancies

Disease Types: Breast, Gastric/Gastroesophageal Junction

USOR 13-079
A Phase III randomized, 3-arm, open label, multicenter study of LGX818 plus MEK162 and LGX818 monotherapy compared with vemurafenib in patients with unresectable or metastatic BRAF V600 mutant melanoma

Disease Types: Melanoma

Galena/Genentech ML25749
Combination immunotherapy with Herceptin and the HER2 vaccine E75 in low and intermediate HER2-expressing breast cancer patients to prevent recurrence

Disease Types: Breast

Side-Out Foundation SO-BCA-002 Side-Out 2
A Pilot Study Utilizing Proteomic and Genomic Profiling by Reverse Phase Protein Microarray (RPMA), IHC Analysis, RNA-Seq, and Exome Sequencing of Patients’ Tumors to Find Potential Targets and Select Treatments for Patients with Metastatic Breast Cancer

Disease Types: Breast

USOR 13-056
A phase 2 study of brentuximab vedotin in combination with standard of care treatment (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone [RCHOP]) as front-line therapy in patients with diffuse large B-cell lymphoma (DLBCL)

Disease Types: Diffuse Large B-cell Lymphoma

Novartis LDK378A2303
A Phase III, Multicenter, Randomized, Open-label Study of Oral LDK378 Versus Standard Chemotherapy in Adult Patients with ALK-rearranged (ALK-positive) Advanced Non-small Cell Lung Cancer Who Have Been Treated Previously With Chemotherapy (Platinum Doublet) and Crizotinib

Disease Types: Non-Small Cell Lung Cancer

USO 09-141
CONNECT (TM) MM - The Multiple Myeloma Disease Registry - Registry Protocol

Disease Types: Multiple Myeloma